News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
Presentation Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age April 27, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Conference News ACC 2020 TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients Todd Neale March 31, 2020
Presentation ACC 2020 Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial Presenter: Yangsoo Jang March 30, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry Todd Neale January 15, 2020
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Daily News Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD Todd Neale October 29, 2019
News Daily News Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe Yael L. Maxwell October 16, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2019 Caitlin E. Cox May 31, 2019